Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Bonnans

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Molecular Cancer|March 4, 2010
Pregnane X Receptor (PXR) expression in colorectal cancer cells restricts irinotecan chemosensitivity through enhanced SN-38 glucuronidationCaroline Raynal, Jean-Marc Pascussi, Géraldine Leguelinel, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2012
Essential requirement for β-arrestin2 in mouse intestinal tumors with elevated Wnt signalingCaroline Bonnans, Maud Flacelière, Fanny Grillet, et al.
Oncoimmunology|June 8, 2023
23ME-00610, a genetically informed, first-in-class antibody targeting CD200R1 to enhance antitumor T cell functionJill Fenaux, Xin Fang, Yao-Ming Huang, et al.
JCI Insight|June 26, 2019
RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancerOghenekevwe M Gbenedio, Caroline Bonnans, Delphine Grun, et al.
Cancer Research Communications|March 21, 2025
23ME-01473, an Fc Effector-Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell-Mediated Antitumor Immunity through NKG2D and FcγRIIIa ActivationJoel S Benjamin, Abigail Jarret, Shashank Bharill, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Molecular Cancer|March 4, 2010
Pregnane X Receptor (PXR) expression in colorectal cancer cells restricts irinotecan chemosensitivity through enhanced SN-38 glucuronidationCaroline Raynal, Jean-Marc Pascussi, Géraldine Leguelinel, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2012
Essential requirement for β-arrestin2 in mouse intestinal tumors with elevated Wnt signalingCaroline Bonnans, Maud Flacelière, Fanny Grillet, et al.
Oncoimmunology|June 8, 2023
23ME-00610, a genetically informed, first-in-class antibody targeting CD200R1 to enhance antitumor T cell functionJill Fenaux, Xin Fang, Yao-Ming Huang, et al.
JCI Insight|June 26, 2019
RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancerOghenekevwe M Gbenedio, Caroline Bonnans, Delphine Grun, et al.
Cancer Research Communications|March 21, 2025
23ME-01473, an Fc Effector-Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell-Mediated Antitumor Immunity through NKG2D and FcγRIIIa ActivationJoel S Benjamin, Abigail Jarret, Shashank Bharill, et al.
Pageof 3